Members Login
 

The WHO Early Release Guideline on ARV and PrEP

were published on September

30th, 2015 and can be

found here:

 Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV

JIAS Special Issue: PrEP Implementation Science: State-of-the-Art and Research Agenda, organized by NEMUS (published July 2015).

 Please visit Nemus´Youtube channell

 

Follow us in Facebook

 

and Twiter

NEMUS Activities 2016

Special NEMUS Global Webinar Program for World AIDS Day (Webinars 25, 26 and 27) Featured

Rate this item
(0 votes)

Dear colleague:

 

On occasion of World AIDS Day 2016, NEMUS is pleased to offer a Special Program of 3 presentation of its Global Webinar Series:

-  On Tuesday 22 November, Sybil Hosek, PhD and Alejandra Trossero, MA, will present on an increasingly important topic globally: PrEP and Adolescents at Risk: Existing Evidence and Plans for a Demonstration Study.

-  On Monday 28 November, Raphael Landovitz, MD, who was one of the Lead Rapporteurs at the recent R4P Conference, will present on ARV-based prevention and PrEP research - News from the 2016 Research for Prevention Conference.

-  On Monday, 5 December, Jerome Galea, PhD, who is in charge of the PrEP in the Wild Study of individual/community led access to PrEP, will present on PrEP in the Wild - An interim Analysis.


All webinars will take place at 7am (PST), 9am (Mexico City) 10am (EST, Lima, Panama), 12m (Buenos Aires), 1pm (Brasilia, Rio), 3pm (London), 4pm (CST), 5pm (Johannesburg), 10pm (Bangkok), 2am 1 (Sydney). For other locations, please check:

 

http://www.worldtimeserver.com/meeting-planner.aspx

 

PrEP and Adolescents at Risk: Existing Evidence and Plans for a Demonstration Study
(22 November)

sibil hosek

Sybil Hosek is a Clinical Psychologist/HIV Researcher at Stroger Hospital of Cook County with over 15 years experience in the development and implementation of HIV-related research studies and behavioral interventions. Her current research focuses on biomedical primary prevention interventions, for adolescents and young adults, including PrEP and microbicides, and the development of behavioral interventions to improve uptake and adherence to these new biomedical strategies. Dr. Hosek is currently vice-chair of the IMPAACT Prevention Scientific Committee, a member of the HPTN Adolescents At Risk Scientific Committee, and co-chair of the HANC Youth Prevention Research Working Group.

 

Alejandra Trossero

Alejandra Trossero recently joined UNICEF Latin American and the Caribbean Regional office as the Regional Adolescent and HIV/AIDS Specialist. Alejandra has over 18 years of experience working on HIV and sexual and reproductive health (SRH). Prior to joining UNICEF, she hold positions at UNDP and the International Planned Parenthood Federation (IPPF), focusing on HIV and SRH integration, establishing a 5-year research program in three Sub-Saharan Africa countries to assess the efficacy and cost-benefit of integrating HIV and SRH services – with Population Council and London School of Hygiene and Tropical Medicine. She is currently serving as the Chair of the Program Advisory Panel at the Robert Carr Civil Society Network Fund. Alejandra, who hails from Argentina, has a degree in Psychology and a Masters in Science in Reproductive and Sexual Health Research from the London School of Hygiene and Tropical Medicine.

To register for the webinar please click on the following link:

 

https://goo.gl/forms/gHS3HsaflKdvBpU02

 

ARV-based prevention and PrEP research - News from the 2016 Research for Prevention Conference
(28 November)

Rafael Landovitz

Raphael J Landovitz´s clinical research career focuses on optimizing the use of HIV antiretroviral therapy for both HIV treatment and HIV prevention.
Dr. Landovitz was trained at Princeton University and Harvard Medical School. He completed post-graduate training in internal medicine at Brigham and Women’s Hospital (1996-1999) and Infectious Diseases and HIV Medicine at Brigham and Women’s Hospital and Massachusetts General Hospital (1999-2001). The served as Chief Medical Resident at the Brigham and Women’s Hospital from 2001-2002. He served on the faculty of the Division of Infectious Diseases at the Brigham and Women’s Hospital from 2001-2005, and then as Medical Co-Director of the Vietnam CDC-Harvard Medical School AIDS Partnership. He is Currently Associate Professor of Medicine in the Division of Infectious Diseases at UCLA, Associate Director of the UCLA Center for Clinical AIDS Research & Education, and Co-Director of the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS). He is leading the NIH/DAIDS funded Phase 2a and Phase 3 studies of long-acting injectable PrEP using cabotegravir (GSK 1265744). He was awarded the John Carey Young Investigator Award by the AIDS Clinical Trials Group in 2010..

To register for the webinar please click on the following link:

 

https://goo.gl/forms/2BxXvMKKGb0AYsKI2

 

PrEP in the Wild - An interim Analysis
(05 December)

Jerome Galea

Jerome Galea is the Deputy Director of Partners in Health and the co-founder of the LGTB Epicenter community center, both organizations in Lima, Peru, and a postdoctoral Fellow at the Harvard Medical School. He has studied and published on the acceptability of PrEP in Peru and is currently investigating the informal use of PrEP in the Wild PrEP study.

To register for the webinar please click on the following link:

 

https://goo.gl/forms/0xsEvSQuFL8BHflE2

 

After you register you will receive a confirmation e-mail with instructions to access the webinar and background readings.Looking forward to your participation. 

 

Share this

Submit to DeliciousSubmit to DiggSubmit to FacebookSubmit to Google PlusSubmit to StumbleuponSubmit to TechnoratiSubmit to TwitterSubmit to LinkedIn
Read 498 times Last modified on Tuesday, 22 November 2016 18:33

Media